Cargando…

Close Correlation of 1‐β‐D‐Arabinofuranosylcytosine 5′‐Triphosphate, an Intracellular Active Metabolite, to the Therapeutic Efficacy of N(4)‐Behenoyl‐1‐β‐D‐arabinofuranosylcytosine Therapy for Acute Myelogenous Leukemia

N(4)‐Behenoyl‐l‐β‐D‐arabinofuranosylcytosine (BHAC), a prodrug of 1‐β ‐D‐arabinofuranosylcy‐tosine, is used effectively for the treatment of leukemia in Japan. BHAC therapy may be more effective if it is delivered in conjunction with monitoring of 1‐β ‐D‐arabinofuranosylcytosine 5′‐tri‐phosphate (ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamauchi, Takahiro, Kawai, Yasukazu, Goto, Nobuyuki, Kishi, Shinji, Imamura, Shin, Yoshida, Akira, Urasaki, Yoshimasa, Fukushima, Toshihiro, Iwasaki, Hiromichi, Tsutani, Hiroshi, Masada, Mikio, Ueda, Takanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2001
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926845/ https://www.ncbi.nlm.nih.gov/pubmed/11572766 http://dx.doi.org/10.1111/j.1349-7006.2001.tb01188.x

Ejemplares similares

Monitoring of Intracellular l‐βD‐Arabinofuranosylcytosine 5′‐Triphosphate in 1‐β‐D‐Arabinofuranosylcytosine Therapy at Low and Conventional Doses
por: Yamauchi, Takahiro, et al.
Publicado: (2001)

l‐β‐D‐Arabinofuranosylcytosine Is Cytotoxic in Quiescent Normal Lymphocytes Undergoing DNA Excision Repair
por: Yamauchi, Takahiro, et al.
Publicado: (2002)

Antitumor Activity and Pharmacology of 1‐β‐D‐Arabinofuranosylcytosine‐5′‐stearylphosphate: An Orally Active Derivative of 1‐β‐D‐Arabinofuranosylcytosine
por: Kodama, Kenjiro, et al.
Publicado: (1989)

Modulation of the Effect of l‐β‐D‐Arabinofuranosylcytosine by 6‐Mercaptopurine in L1210 Cells
por: Kawai, Yasukazu, et al.
Publicado: (1994)

Metabolism and Toxicity of Electroporated 1‐β‐d‐Arabinofuranosylcytosine Triphosphate in a Human Leukemia Cell Line
por: Kubota, Masaru, et al.
Publicado: (1990)

Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.
por: Horber, D. H., et al.
Publicado: (1995)

TMSOTf assisted synthesis of 2’-deoxy-2’-[(18)F]fluoro-β-D-arabinofuranosylcytosine ([(18)F]FAC)
por: Gangangari, Kishore K., et al.
Publicado: (2018)

1-beta-D-arabinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukaemic cells.
por: Muus, P., et al.
Publicado: (1991)

Enhancement of Ca(2+)‐dependent Endonuclease Activity in L1210 Cells during Apoptosis Induced by 1‐β‐D‐Arabinofuranosylcytosine: Possible Involvement of Activating Factor(s)
por: Takauji, Rumiko, et al.
Publicado: (1995)

Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N(4)-octadecyl-1-β-D-arabinofuranosylcytosine in Daudi lymphoma cells
por: Koller-Lucae, S K M, et al.
Publicado: (1999)

Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecyl-1-beta-D-arabinofuranosylcytosine.
por: Horber, D. H., et al.
Publicado: (1995)

Synergistic and antagonistic AML cell type-specific responses to 5-AZA-2’-Deoxycytidine and 1-H-D-Arabinofuranosylcytosine
por: Elmoneim, Abeer Abd, et al.
Publicado: (2014)

Behenoyl cytarabine-associated reversible encephalopathy in a patient with acute myelogenous leukemia.
por: Cho, S. G., et al.
Publicado: (1999)

Development and validation of assays for the quantification of β-D-N(4)-hydroxycytidine in human plasma and β-D-N(4)-hydroxycytidine-triphosphate in peripheral blood mononuclear cell lysates
por: Parsons, Teresa L., et al.
Publicado: (2021)

Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome
por: TAKAI, MIHOKO, et al.
Publicado: (2014)

The Antitumor Mechanism of 1‐(2‐Deoxy‐2‐fluoro‐4‐thio‐β‐D‐arabinofuranosyl)‐cytosine: Effects of Its Triphosphate on Mammalian DNA Polymerases
por: Miura, Shinji, et al.
Publicado: (2001)

Synthesis of a Biologically Important Adenosine Triphosphate Analogue, ApppD
por: Turhanen, Petri A.
Publicado: (2017)

Clinical Efficacy of Polycaprolactone β-Calcium Triphosphate Composite for Osteoconduction in Rabbit Bone Defect Model
por: Chen, Chiu-Ming, et al.
Publicado: (2021)

Correction to “Synthesis of a Biologically Important Adenosine Triphosphate Analogue, ApppD”
por: Turhanen, Petri A.
Publicado: (2017)

Myelogenic Leukaemia
Publicado: (1915)

β-d-Altrose
por: Watanabe, Yuji, et al.
Publicado: (2009)

β-d-Gulose
por: Ishii, Tomohiko, et al.
Publicado: (2014)

NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia
por: Wang, Xiao, et al.
Publicado: (2023)

Incorporation of non-nucleoside triphosphate analogues opposite to an abasic site by human DNA polymerases β and λ
por: Crespan, Emmanuele, et al.
Publicado: (2005)

Novel mechanism of impaired metabolism‐secretion coupling in β‐cells: Loss of cytosolic adenosine triphosphate by leakage
por: Fujimoto, Shimpei
Publicado: (2019)

Idarubicin Plus Behenoyl Cytarabine and 6-thioguanine Compares Favorably with Idarubicin Plus Cytarabine-based Regimen for Children with Previously Untreated Acute Myeloid Leukemia: 10-Year Retrospective, Multicenter Study in Korea
por: Lee, Dae Hyoung, et al.
Publicado: (2010)

Improved Synthesis of β-D-6-Methylpurine Riboside and Antitumor Effects of the β-D- and α-D-Anomers
por: Marasco, Canio J., et al.
Publicado: (2005)

Breaking tumor-induced immunosuppression with 5′-triphosphate siRNA silencing TGFβ and activating RIG-I
por: Schnurr, Max, et al.
Publicado: (2013)

The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells
por: Naka, Kazuhito, et al.
Publicado: (2020)

Synthesis of the biologically important dideuterium-labelled adenosine triphosphate analogue ApppI(d(2))
por: Turhanen, Petri A
Publicado: (2022)

Seleno-detergent MAD phasing of leukotriene C(4) synthase in complex with dodecyl-β-d-selenomaltoside
por: Saino, Hiromichi, et al.
Publicado: (2011)

Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group
por: Sakai, Tomoyuki, et al.
Publicado: (2015)

Functional adenosine triphosphate‐sensitive potassium channel is required in high‐carbohydrate diet‐induced increase in β‐cell mass
por: Murase, Masatoshi, et al.
Publicado: (2018)

Synthesis and In Vitro Screening of Novel Heterocyclic β-d-Gluco- and β-d-Galactoconjugates as Butyrylcholinesterase Inhibitors
por: Baumann, Krešimir, et al.
Publicado: (2019)

Inhibition of Nucleotide Excision Repair by Fludarabine in Normal Lymphocytes in vitro, Measured by the Alkaline Single Cell Gel Electrophoresis (Comet) Assay
por: Yamauchi, Takahiro, et al.
Publicado: (2002)

Acquired Class D β-Lactamases
por: Antunes, Nuno T., et al.
Publicado: (2014)

Immunotherapy for Acute Myelogenous Leukaemia
por: Powles, R. L., et al.
Publicado: (1973)

Chronic myelogenous leukemia in Libya
por: Mehdi, Itrat, et al.
Publicado: (2012)

Myelogenous Leukæmia and Its Treatment
por: Debove,
Publicado: (1910)

Chronic myelogenous leukemia on target
por: Némethová, Veronika, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cut3s4hq50hqr1oaght3filpmn